Charles River Laboratories International (CRL) Competitors $162.45 +0.20 (+0.12%) As of 01:10 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends CRL vs. MTD, WAT, ILMN, TECH, BIO, BRKR, PACB, HBIO, TMO, and AShould you be buying Charles River Laboratories International stock or one of its competitors? The main competitors of Charles River Laboratories International include Mettler-Toledo International (MTD), Waters (WAT), Illumina (ILMN), Bio-Techne (TECH), Bio-Rad Laboratories (BIO), Bruker (BRKR), Pacific Biosciences of California (PACB), Harvard Bioscience (HBIO), Thermo Fisher Scientific (TMO), and Agilent Technologies (A). These companies are all part of the "life sciences tools & services" industry. Charles River Laboratories International vs. Mettler-Toledo International Waters Illumina Bio-Techne Bio-Rad Laboratories Bruker Pacific Biosciences of California Harvard Bioscience Thermo Fisher Scientific Agilent Technologies Mettler-Toledo International (NYSE:MTD) and Charles River Laboratories International (NYSE:CRL) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, valuation, community ranking, analyst recommendations, earnings, institutional ownership, risk, dividends and media sentiment. Which has preferable valuation and earnings, MTD or CRL? Mettler-Toledo International has higher earnings, but lower revenue than Charles River Laboratories International. Mettler-Toledo International is trading at a lower price-to-earnings ratio than Charles River Laboratories International, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMettler-Toledo International$3.87B6.95$863.14M$40.5331.72Charles River Laboratories International$4.05B2.05$474.62M$0.151,083.00 Does the media favor MTD or CRL? In the previous week, Charles River Laboratories International had 16 more articles in the media than Mettler-Toledo International. MarketBeat recorded 34 mentions for Charles River Laboratories International and 18 mentions for Mettler-Toledo International. Mettler-Toledo International's average media sentiment score of 1.71 beat Charles River Laboratories International's score of 0.74 indicating that Mettler-Toledo International is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Mettler-Toledo International 17 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Charles River Laboratories International 15 Very Positive mention(s) 1 Positive mention(s) 7 Neutral mention(s) 4 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders and institutionals hold more shares of MTD or CRL? 95.1% of Mettler-Toledo International shares are held by institutional investors. Comparatively, 98.9% of Charles River Laboratories International shares are held by institutional investors. 1.9% of Mettler-Toledo International shares are held by insiders. Comparatively, 1.3% of Charles River Laboratories International shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Which has more risk & volatility, MTD or CRL? Mettler-Toledo International has a beta of 1.13, meaning that its stock price is 13% more volatile than the S&P 500. Comparatively, Charles River Laboratories International has a beta of 1.37, meaning that its stock price is 37% more volatile than the S&P 500. Is MTD or CRL more profitable? Mettler-Toledo International has a net margin of 22.29% compared to Charles River Laboratories International's net margin of 0.52%. Charles River Laboratories International's return on equity of 14.69% beat Mettler-Toledo International's return on equity.Company Net Margins Return on Equity Return on Assets Mettler-Toledo International22.29% -591.54% 26.78% Charles River Laboratories International 0.52%14.69%6.79% Do analysts rate MTD or CRL? Mettler-Toledo International currently has a consensus target price of $1,368.00, suggesting a potential upside of 6.41%. Charles River Laboratories International has a consensus target price of $195.71, suggesting a potential upside of 20.48%. Given Charles River Laboratories International's higher possible upside, analysts plainly believe Charles River Laboratories International is more favorable than Mettler-Toledo International.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Mettler-Toledo International 1 Sell rating(s) 6 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.11Charles River Laboratories International 3 Sell rating(s) 12 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 1.88 Does the MarketBeat Community believe in MTD or CRL? Charles River Laboratories International received 122 more outperform votes than Mettler-Toledo International when rated by MarketBeat users. Likewise, 59.83% of users gave Charles River Laboratories International an outperform vote while only 56.64% of users gave Mettler-Toledo International an outperform vote. CompanyUnderperformOutperformMettler-Toledo InternationalOutperform Votes37156.64% Underperform Votes28443.36% Charles River Laboratories InternationalOutperform Votes49359.83% Underperform Votes33140.17% SummaryMettler-Toledo International and Charles River Laboratories International tied by winning 9 of the 18 factors compared between the two stocks. Get Charles River Laboratories International News Delivered to You Automatically Sign up to receive the latest news and ratings for CRL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CRL vs. The Competition Export to ExcelMetricCharles River Laboratories InternationalCommercial physical research IndustryMedical SectorNYSE ExchangeMarket Cap$8.30B$4.07B$5.81B$20.14BDividend YieldN/A1.83%4.78%3.65%P/E Ratio1,082.19110.8426.2335.11Price / Sales2.05296.94453.4315.89Price / Cash7.6031.2944.0420.85Price / Book2.403.047.664.95Net Income$474.62M$118.81M$3.18B$1.02B7 Day Performance6.83%-2.40%-1.36%-0.48%1 Month Performance-4.35%34.58%0.73%-0.82%1 Year Performance-32.62%11.88%17.60%14.68% Charles River Laboratories International Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CRLCharles River Laboratories International4.7321 of 5 stars$162.45+0.1%$195.71+20.5%-31.9%$8.30B$4.05B1,082.1921,800Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageMTDMettler-Toledo International3.9606 of 5 stars$1,273.44-1.8%$1,368.00+7.4%+10.0%$26.64B$3.87B31.4217,300Positive NewsWATWaters4.0542 of 5 stars$369.71-2.5%$390.40+5.6%+17.6%$21.95B$2.96B35.287,900ILMNIllumina4.8069 of 5 stars$100.24-1.5%$159.45+59.1%-30.6%$15.90B$4.37B-13.059,300TECHBio-Techne4.9436 of 5 stars$65.94-1.2%$86.57+31.3%-6.9%$10.48B$1.16B66.613,100Analyst DowngradeInsider TradeBIOBio-Rad Laboratories4.7997 of 5 stars$276.55-9.7%$395.20+42.9%-16.7%$7.74B$2.57B-10.128,030High Trading VolumeBRKRBruker4.8783 of 5 stars$50.04-2.2%$70.50+40.9%-34.7%$7.59B$2.96B24.069,707PACBPacific Biosciences of California2.3411 of 5 stars$1.85+25.0%$2.85+54.3%-69.0%$506.64M$200.52M-1.27730Analyst ForecastOptions VolumeAnalyst RevisionNews CoverageGap UpHigh Trading VolumeHBIOHarvard Bioscience2.2177 of 5 stars$1.35+1.5%N/A-72.7%$58.89M$112.25M-4.09490Gap DownTMOThermo Fisher Scientific4.778 of 5 stars$532.580.0%$658.00+23.5%-1.9%$203.71B$42.88B32.22122,000Dividend IncreaseAnalyst RevisionPositive NewsAAgilent Technologies4.4101 of 5 stars$134.57-1.4%$144.38+7.3%+1.9%$38.39B$6.51B30.4517,900Upcoming EarningsDividend AnnouncementPositive News Related Companies and Tools Related Companies Mettler-Toledo International Alternatives Waters Alternatives Illumina Alternatives Bio-Techne Alternatives Bio-Rad Laboratories Alternatives Bruker Alternatives Pacific Biosciences of California Alternatives Harvard Bioscience Alternatives Thermo Fisher Scientific Alternatives Agilent Technologies Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:CRL) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Charles River Laboratories International, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Charles River Laboratories International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CRL Stock Alerts